Lamictal (Lamotrigine) and Kidney Function: Safety and Monitoring
Lamotrigine (Lamictal) is primarily metabolized by hepatic glucuronidation (UGT1A4). Renal excretion of unchanged drug is minimal (~10%).
Kidney Safety Profile
- No significant nephrotoxicity in clinical trials or post-marketing
- Safe in mild–moderate CKD (eGFR 30–89 mL/min) without dose adjustment
- In severe CKD (eGFR <30) or ESRD on dialysis: limited data; consider dose reduction (↓25–50%) and monitor for adverse effects (rash, dizziness, ataxia)
- Hemodialysis removes some lamotrigine; post-dialysis supplemental dose may be needed
Clinical Recommendations
- Inform prescriber of any kidney disease
- Baseline and periodic renal function monitoring if CKD present
- Do not adjust or stop without medical supervision (risk of seizure recurrence, withdrawal)
- Watch for drug interactions: valproate ↑ lamotrigine levels; carbamazepine/phenytoin ↓ levels
Overall, lamotrigine is considered kidney-friendly among antiseizure medications.
Kidney Disease - Related Articles
- Newborn Kidney Infection: Symptoms, Signs & What to Watch For
- What the Kidneys Filter: Comprehensive List of Substances
- Natural Kidney Stone Remedies: Nutrition & Prevention
- Cardiorenal: Heart-Kidney Interactions in Health & Disease
- Natural Ways to Support Kidney Health
- Prevent Kidney Decline: A Dietary Guide for Optimal Health
- Adrenal Nodules: Symptoms, Diagnosis & Testing
